Skip to main content
SpringerLink
Log in

Functional Dyspepsia

Current Treatment Recommendations

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Symptoms of functional dyspepsia are frequent; the prevalence of dyspepsia (defined as pain or discomfort centred in the upper abdomen) in the general population approaches 25%. By definition, patients with functional dyspepsia do not have a structural or biochemical explanation for their symptoms. Disorders of function (e.g. delayed gastric emptying) are detectable in a proportion of patients but remain poorly understood.

Nevertheless, the current rationale for drug treatment is based on altering pathophysiological mechanisms which are believed to be associated with the development of symptoms. Although the placebo response rates approach 60%, prokinetics, acid-suppressing agents and bismuth-containing compounds have been shown to be significantly better than placebo in reducing symptoms. Antacids are widely used, but no controlled study has been able to demonstrate a significant benefit over placebo. The efficacy of sucralfate is uncertain.

Rational guidelines on which drug should be used for a given patient are lacking, although approaches based on symptom profiles have been proposed; the duration of treatment needed to achieve long-lasting relief of symptoms is also poorly defined. Identifying optimal treatment for the individual patient, therefore, continues to be largely a trial and error process. Further research efforts are needed to elucidate the pathophysiological basis of functional dyspepsia so that specific therapy can be tailored to underlying pathophysiological disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agorastos I, Zissis NP, Kaprinis I, Goulis G. Double-blind evaluation of domperidone in acute vomiting and dyspeptic disorders. Journal of International Medical Research 9: 143–147, 1981

    Article  CAS  PubMed  Google Scholar 

  • Arts E, Anthoni H, de Roy G, D’Hollander J, Verhaegen H. Domperidone in the treatment of dyspepsia: a double-blind placebo-controlled study. Journal of International Medical Research 7: 158–161, 1979

    Article  CAS  PubMed  Google Scholar 

  • Barbara L, Biasco G, Capurso L, Dobrilla G, Lalli A, et al. Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia. American Journal of Gastroenterology 85: 1109–1113,1990

    CAS  PubMed  Google Scholar 

  • Bate CM, Richardson PDI. Clinical and economic factors in selection of drugs for gastroesophageal reflux disease. PharmacoEconomics 3: 94–99, 1993

    Article  CAS  PubMed  Google Scholar 

  • Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgraduate Medical Journal 55 (Suppl.1): 30–32, 1979

    PubMed  Google Scholar 

  • Berndtsen F, Dano P, Guldhammer B, Remvig L, Krogsoe O. Cimitidine behandling af nontgennegativ dyspepsi. Ugeskrift foer Laeger 145: 3090–3093, 1983

    Google Scholar 

  • Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102: 720–727, 1992

    Article  CAS  PubMed  Google Scholar 

  • Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. Journal of Infectious Diseases 161: 626–633, 1990

    Article  CAS  PubMed  Google Scholar 

  • Bradette M, Pare P, Douville P, Morin A. Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Digestive Diseases and Sciences 36: 52–58, 1991

    CAS  PubMed  Google Scholar 

  • Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut 29: 631–635, 1988

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Champion MC. Domperidone. General Pharmacology 19: 499–505,1988

    Article  CAS  PubMed  Google Scholar 

  • Chiba N, Rao BV, Rademaker JW, Hunt RW. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. American Journal of Gastroenterology 87: 1716–1727, 1992

    CAS  PubMed  Google Scholar 

  • Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, et al. Management of dyspepsia: report of a working party. Lancet 1: 576–579, 1988

    Google Scholar 

  • Corinaldesi R, Raiti C, Stanghellini V, Moriediti N, Rea E, et al. Comparative effects of oral cisapride and metoclopramide on gastric emptying of solids and symptoms in patients with functional dyspepsia and gastroparesis. Current Therapeutic Research 42: 428–435, 1987a

    Google Scholar 

  • Corinaidesi R, Stanghellini V, Raiti C, Rea E, Salgemini R, et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 28: 300–305, 1987b

    Article  Google Scholar 

  • Coutant G, Francois I, DeNutte N, DeCock G, Borgers P, et al. Dose response study of cisapride in the management of non-ulcer dyspepsia. Progress in Medicine 43 (Suppl. 1): 91–96, 1987

    Google Scholar 

  • Creytens G. Effect of the non-antidopaminergic drug cisapride on postprandial nausea. Current Therapeutic Research 36: 1063–1069, 1984

    Google Scholar 

  • Dal Monte PR, D’Imperio N, Accardo P, Daniotti S. Pirenzepine in non-ulcer dyspepsia. A double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 17 (Suppl. 72): 247–250, 1982

    Google Scholar 

  • Davis RH, Clench MH, Mathias JR. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study. Digestive Diseases and Sciences 33: 1505–1511, 1988

    Article  CAS  PubMed  Google Scholar 

  • Delattre M, Malesky M, Prinzie A. Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Current Therapeutic Research 37: 980–991, 1985

    Google Scholar 

  • De Loose F. Domperidone in chronic dyspepsia: a pilot open study and a multicentre general practice crossover comparison with metoclopramide and placebo. Pharmatherapeutica 2: 140–146, 1979

    Google Scholar 

  • De Nutte N, Van Ganse W, Wetterbulghe M, Defrance P. Relief of epigastric pain in non-ulcer dyspepsia: controlled trial of the promotility drug cisapride. Clinical Therapeutics 11: 62–68, 1989

    PubMed  Google Scholar 

  • Deruyttere M, Milo R, Creytens G, Goethals C, Bourgeois E, et al. Therapy of chronic functional dyspepsia: multicenter crossover study of cisapride and placebo. Progress in Medicine 43 (Suppl. 1): 61–68, 1987

    Google Scholar 

  • Dill S, Payne-James JJ, Misiewicz JJ, Grimble GK, McSwiggan D, et al. Evaluation of the 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitrobismuthate in non ulcer dyspepsia. Gut 31: 1237–1241, 1990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled trials. Journal of Clinical Gastroenterology 11: 169–177, 1989

    Article  CAS  PubMed  Google Scholar 

  • Dooley CP, Cohen H, Fitzgibbons P, Bauer M, Appleman MD, et al. Prevalence of Helicobacter pylori and histologic gastritis in asymptomatic persons. New England Journal of Medicine 321: 1562–1566, 1989

    Article  CAS  PubMed  Google Scholar 

  • Drossman DA, Thompson WG, Talley, NJ, Funch-Jensen P, Janssens J, et al. Identification of subgroups of functional gastrointestinal disorders. Gastroenterology International 3: 159–172, 1990

    Google Scholar 

  • Englert W, Schlich D. A double-blind crossover trial of domperidone in chronic postprandial dyspepsia. Postgraduate Medical Journal 55 (Suppl. 1): 28–29, 1979

    PubMed  Google Scholar 

  • Farup PG, Larsen S, Ulshagen K, Osnes M. Ranitidime for nonulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. Scandinavian Journal of Gastroenterology 26: 1209–1216, 1991

    CAS  Google Scholar 

  • Farup PG, Tjora S, Tholfsen JK. Effect of cisapride on symptoms and biliary drainage in patients with postcholecystectomy syndrome. Scandinavian Journal of Gastroenterology 26: 945–950, 1991

    Article  CAS  PubMed  Google Scholar 

  • Francois I, De Nutte N. Non-ulcer dyspepsia. Effect of the gastrointestinal prokinetic drug cisapride. Current Therapeutic Research 41: 891–898, 1987

    Google Scholar 

  • Gilbert RJ, Dodds WJ, Kahrilas PJ, Hogan WJ, Lipman S. Effect of cisapride, a new prokinetic agent, on esophageal motor function. Digestive Diseases and Sciences 32: 1331–1336, 1987

    Article  CAS  PubMed  Google Scholar 

  • Glupczynski Y, Burette A, Labbe M, Deprez C, De Reuck M, et al. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. American Journal of Gastroenterology 83: 365–372, 1988

    CAS  PubMed  Google Scholar 

  • Goethals C, Van de Mierop L. Cisapride in the treatment of chronic functional dyspepsia. Results of a double-blind, placebo-controlled, crossover study. Current Therapeutic Research 42: 261–267, 1987

    Google Scholar 

  • Gotthard R, Bodemar G, Brodin U, Jönsson K-A. Treatment with cimetidine, antacid or placebo in patients with dyspepsia of unknown origin. Scandinavian Journal of Gastroenterology 23: 7–18,1988

    Article  CAS  PubMed  Google Scholar 

  • Haarmann K, Lebkuchner F, Widmann A, Kief W, Esslinger M. A double-blind study of domperidone in the symptomatic treatment of chronic postprandial upper gastrointestinal distress. Postgraduate Medical Journal 55 (Suppl. 1): 24–27, 1979

    PubMed  Google Scholar 

  • Hailey FJ, Newsom JG. Evaluation of bismuth subsalicylate in relieving symptoms of indigestion. Archives of Internal Medicine 144: 269–272, 1984

    Article  CAS  PubMed  Google Scholar 

  • Hannon R. Efficacy of cisapride in patients with non-ulcer dyspepsia. A placebo-controlled study. Current Therapeutic Research 42: 814–822, 1987

    Google Scholar 

  • Hausken T, Berstad A. Cisapride treatment of pateints with nonulcer dyspepsia and erosive prepylorioc changes. A double placebo controlled trial. Scandinavian Journal of Gastroenterology 27: 213–217, 1992

    Article  CAS  PubMed  Google Scholar 

  • Hausken T, Stene-Larsen G, Lange O, Aronsen O, Nerdrum T, et al. Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scandinavian Journal of Gastroenterology 25: 1028–1033, 1990

    Article  CAS  PubMed  Google Scholar 

  • Holcombe C, Thorn C, Kaluba J, Lucas SB. Helicobacter pylori clearance in the treatment of non-ulcer dyspepsia. Alimentary Pharmacology and Therapeutics 6: 119–123 1992

    Article  CAS  PubMed  Google Scholar 

  • Holtmann G, Goebell, H. Ursachen der funktionellen Dyspepsie. Deutsche Medizinische Wochenschrift 117: 1029–1034, 1992

    Article  CAS  PubMed  Google Scholar 

  • Hradsky M, Wikander M. Effect of pirenzepine in the treatment of non-ulcer dyspepsia. A double-blind study. Scandinavian Journal of Gastroenterology 17 (Suppl. 72): 251–254, 1982

    Google Scholar 

  • Hui WM, Lam SK, Lok ASF, Ng MMT, Wong KL, et al. Sulpiride improves functional dyspepsia: a double-blind controlled study. Journal of Gastroenterology and Hepatology 1: 391–399, 1986

    Article  Google Scholar 

  • Jian R, Ducrot F, Ruskone A, Chaussade S, Rambaud JC, et al. Symptomatic radionuclide and therapeutic assessment of chronic idiopathic dyspepsia: a double-blind placebo-controlled evaluation of cisapride. Digestive Diseases and Sciences 34: 657–664, 1989

    Article  CAS  PubMed  Google Scholar 

  • Johannessen T. Controlled trials in single subjects. 1. Value in clinical medicine. British Medical Journal 303: 173–174, 1991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johannessen T, Fjøsne U, Kleveland M, Halvorsen T, Kristensen P, et al. Cimetidine responders in non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology 23: 327–336, 1988

    Article  CAS  PubMed  Google Scholar 

  • Johannessen T, Kristensen P, Petersen H, Fosstvedt D, Løge I, et al. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials. Scandinavian Journal of Gastroenterology 26: 974–980, 1991

    CAS  PubMed  Google Scholar 

  • Johannessen T, Petersen H, Kristensen P, Fosstvedt D, Kleveland PM, et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scandinavian Journal of Gastroenterology 27: 189–195, 1992

    CAS  PubMed  Google Scholar 

  • Johnson AG. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. British Medical Journal 2: 25–26, 1971

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kagan G, Huddlestone L, Wolstencroft P. Comparison of diclomine with antacid and without antacid in dyspepsia. Journal of International Medical Research 12: 174–178, 1984

    Article  CAS  PubMed  Google Scholar 

  • Kairaluoma MI, Hentilae R, Alavaikko M, Kellosalo J, Stabilbert M, et al. Sucralfate versus placebo in treatment of non-ulcer dyspepsia. American Journal of Medicine 83 (Suppl. 3B): 51–55, 1987

    Article  CAS  PubMed  Google Scholar 

  • Kang JY, Tay HH, Wee A, Guan R, Math MV, et al. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double-blind, placebo-controlled study. Gut 31: 476–480, 1990

    CAS  PubMed  Google Scholar 

  • Kelbaek H, Linde J, Eriksen J, Munkgaard S, Moesgaard F, et al. Controlled clinical trial of treatment with cimetidine for nonulcer dyspepsia. Acta Medica Scandinavica 217: 281–287, 1985

    Article  CAS  PubMed  Google Scholar 

  • Kleveland PM, Johannessen T, Kristensen P, Loge I, Sandbakken P, et al. Effect of pancreatic enzymes in non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology 25: 298–301, 1990

    CAS  PubMed  Google Scholar 

  • Lambert JR, Borromeo M, Korman MG, Hansky J. Role of Campylobacter pyloridis in non-ulcer dyspepsia — a randomized controlled trial. Gastroenterology 92: 1488, 1987

    Google Scholar 

  • Lance P, Wastell C, Schiller KFR. A controlled trial of cimetidine for the treatment of non-ulcer dyspepsia. Journal of Clinical Gastroenterology 8: 414–418, 1986

    Article  CAS  PubMed  Google Scholar 

  • Lewis JA. Controlled trials in single subjects. 2. Limitations of use. British Medical Journal 303: 175–176, 1991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loffeld RJLF, Potters HVPJ, Arends JN, Stobberingh E, Flendrig JA, et al. Campylobacter associated gastritis in patients with non-ulcer dyspepsia. Journal of Clinical Pathology 41: 85–88, 1988

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loffeld RJLF, Potters HVPJ, Stobberingh E, Flendrig JA, Van Spreeuwel JP, et al. Campylobacter-associated gastritis in patients with non-ulcer dyspepsia: a double-blind, placebocontrolled trial with colloidal bismuth subcitrate. Gut 30: 1206–1212, 1989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Madsen JL. Effects of cisapride on gastrointestinal transit in healthy humans. Digestive Diseases and Sciences 35: 1500–1504, 1990

    Article  CAS  PubMed  Google Scholar 

  • Malagelada JR. Gastrointestinal motor disturbances in functional dyspepsia. Scandinavian Journal of Gastroenterology 26 (Suppl 182): 29–32, 1991

    Article  Google Scholar 

  • Masci E, Bierti L, Testoni PA, Fonti L, Passaretti S, et al. Aluminum-hydroxide-containing antacids and sucralfate in the treatment of reflux gastritis in patients not previously submitted to gastric surgery: comparison with placebo. Current Therapeutic Research 46: 193–199, 1989

    Google Scholar 

  • McNulty CAM, Gearty JC, Crump B, Davis M, Donovan IA, et al. Campylobacter pyloridis and associated gastritis: investigator blind, placebo-controlled trial of bismuth salicylate and erythromycin ethylsuccinate. British Medical Journal 293: 645–649, 1986

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Milo R. Non-cholinergic, non-antidopaminergic treatment of chronic digestive symptoms suggestive of a motility disorder: a two-step pilot evaluation of cisapride. Current Therapeutic Research 36: 1053–1062, 1984

    Google Scholar 

  • Misra SP, Dwivedi M, Misra V, Agarwal SK. Sucralfate versus ranitidine in non-ulcer dyspepsia: results of a prospective randomized, open, controlled trial. Indian Journal of Gastroenterology 11: 7–8, 1992

    CAS  PubMed  Google Scholar 

  • Morgan D, Kraft W, Bender M, Pearson A. Nitrofurans treatment of gastritis associated with campvlobacter pvlori. Gastroenterology 95: 1178–1184, 1988

    Article  CAS  PubMed  Google Scholar 

  • Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causing gastritis and raised fasting pH. American Journal of Gastroenterology 82: 192–199, 1987

    CAS  PubMed  Google Scholar 

  • Nagler J, Miskovitz P. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress. American Journal of Gastroenterology 76: 495–499, 1981

    CAS  PubMed  Google Scholar 

  • Nesland AA, Berstad A. Effect of cimetidine in patients with nonulcer dyspepsia and erosive prepyloric changes. Scandinavian Journal of Gastroenterology 20: 629–635, 1985

    Article  CAS  PubMed  Google Scholar 

  • Nørrelund N, Helles A, Schmiegelow M. Ukaraktäristisk dyspepsi i almen praksis. En kontrolleret undersøgelse med et antacidum (Alminox®). Ugeskrift foer Laeger 142: 1750–1753, 1980

    Google Scholar 

  • Nyrén O, Adami H-O, Bates S, Bergstrom R, Gustavsson S, et al Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. New England Journal of Medicine 314: 339–343, 1986

    Article  PubMed  Google Scholar 

  • Nyrén O Functional dyspepsia-a disorder of the stomach? Gustavssons et al. (Eds) The stomach, pp. 385–415. Longman Group Ltd., New York, 1992

    Google Scholar 

  • Olubuyide IO, Ayoola EA, Okubanjo AO, Atoba MA. Non-ulcer dyspepsia in Nigerians clinical and therapeutic results. Scandinavian Journal of Gastroenterology 21 (Suppl. 124): 83–87, 1986

    Article  Google Scholar 

  • O’Morain. Helicobacter pylori and non-ulcer dyspepsia. Correspondence. Gastroenterology 103: 341, 1992

    Article  Google Scholar 

  • Orme MLE, Tallis RC. Metoclopramide and tardive dyskinesia in the elderly. British Medical Journal 289: 397–298, 1984

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patchett S, Beattie S, Leen E, Keane C, O’Morain C. Helicobacter pylori and non-ulcer dyspepsia. British Medical Journal 303: 1238–1240, 1991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pazzi P, Stabellini G, Trevisani L, Arlotti A, Massari M, et al. Effect of ursodeoxycholic acid (UDCA) on ‘biliary dyspepsia’ in patients without gallstones. Current Therapeutic Research 37: 685–694, 1985

    Google Scholar 

  • Perkel MS, Moore C, Hersh T, Davidson ED. Metoclopramide therapy in patients with delayed gastric emptying. A randomized, double-blind study. Digestive Diseases and Sciences 24: 662–666, 1979

    Article  CAS  PubMed  Google Scholar 

  • Psilogenis M, Nazzari M, Ferrari PA. A multicenter double-blind study of sulglycotide versus sucralfate in nonulcer dyspepsia. International Journal of Clinical Pharmacology Therapy and Toxicology 28: 369–74, 1990

    CAS  Google Scholar 

  • Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, et al. Campylobacter pylori and non-ulcer dyspepsia. American Journal of Gastroenterology 82: 1149–1152, 1987

    CAS  PubMed  Google Scholar 

  • Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, et al. Non-ulcer dyspepsia and short-term ‘De-Nol’ therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 29: 1386–1391, 1988

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rösch W. Cisapride in non-ulcer dyspepsia. Results of a placebocontrolled trial. Scandinavian Journal of Gastroenterology 22: 161–164, 1987

    Article  PubMed  Google Scholar 

  • Sabbatini F, Minieri M, Manzi G, Piai G, D’Angelo V, et al. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study. Italian Journal of Gastroenterology 23: 1–4,1991

    CAS  PubMed  Google Scholar 

  • Sarin SK, Sharma P, Chawla YK, Gopinath P, Nundy S. Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian Journal of Medical Research 83: 623–28, 1986

    CAS  PubMed  Google Scholar 

  • Saunders JHB, Oliver RJ, Higson DL. Dyspepsia: incidence of non-ulcer disease in a controlled trial of ranitidine in general practice. British Medical Journal 292: 665–668, 1986

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schuurkes JAJ, Helsen LFM, Ghoos ECR, Eelen JGM, Van Nueten JM. Stimulation of gastroduodenal motor activity: dopaminergic and cholinergic modulation. Drug Development Research 8: 233–241, 1986

    Article  CAS  Google Scholar 

  • Singal AK, Kumar A, Broor SL. Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study. Current Medical Research and Opinion 11: 390–397, 1989

    Article  CAS  PubMed  Google Scholar 

  • Skoubo-Kristensen E, Funch-Jensen P, Kruse A, Hanberg-Sørensen F, Amdrup E. Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis. Scandinavian Journal of Gastroenterology 24: 716–720, 1989

    Article  CAS  PubMed  Google Scholar 

  • Smith PM, Troughton AH, Gleeson F, Walters J, McCarthy CF. Pirenzpine in non-ulcer dyspepsia: a double-blind placebo controlled trial. Journal of International Medical Research 18: 16–20, 1990

    Article  CAS  PubMed  Google Scholar 

  • Smout AJPM, Bogaard JW, Grade AC, Ten Thife UJ, Akkermans WA, et al. Effects of cisapride, a new gastrointestinal prokinetic substance, on interdigestive and postprandial motor activity of the distal esophagus in man. Gut 26: 246–251, 1985

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stephens CJM, Lever L, Hoare AM. Dicyclomine for idiopathic dyspepsia. Lancet 1: 1004, 1988

    Article  CAS  PubMed  Google Scholar 

  • Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, doubleblind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 91: 149–156, 1986

    Article  CAS  PubMed  Google Scholar 

  • Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Annals of Internal Medicine 108: 865–879, 1988

    Article  CAS  PubMed  Google Scholar 

  • Talley NJ. Chronic (non-specific) gastritis. Digestive Diseases 7: 61–75, 1989

    Article  CAS  PubMed  Google Scholar 

  • Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, et-al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International 4: 145–160, 1991a

    Google Scholar 

  • Talley NJ, Ormand JE, Carpenter HA, Phillips SF. Triple therapy for Helicobacter pylori in non-ulcer dyspepsia. American Journal of Gastroenterology 86: 121–123, 1991b

    CAS  PubMed  Google Scholar 

  • Talley NJ. Drug treatment of functional dyspepsia. Scandinavian Journal of Gastroenterology 26 (Suppl. 182): 47–60, 1991

    Google Scholar 

  • Talley NJ, Zinsmeister, AR, Schleck CD, Melton III LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102: 1259–1268, 1992

    Article  CAS  PubMed  Google Scholar 

  • Tatsuta M, Iishi H, Nakaizumi A, Okuda S. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Alimentary Pharmacology and Therapeutics 6: 221–228, 1992

    Article  CAS  PubMed  Google Scholar 

  • Testoni PA, Bagnolo F, Fanti L, Passaretti S, Titobello A. Long term oral cisapride interdigestive antroduodenal motility in dyspeptic patients. Gut 31: 286–290, 1990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Töndury GD. Die Behandlung eines Syndroms von dyspeptischen Beschwerden mit Ursodesoxycholsäure. Schweizerische Medizinische Rundschau 70: 969–973, 1981

    Google Scholar 

  • Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 96: 1257–1264, 1989

    Article  CAS  PubMed  Google Scholar 

  • Tytgat GNJ, Noach LA, Rauws EAJ. Is gastroduodenitis a cause of chronic dyspepsia? Scandinavian Journal of Gastroenterology 26 (Suppl. 182): 33–39, 1991

    Article  Google Scholar 

  • Van de Mierop L, Rutgeerts L, Van den Langenbergh B, Staessen A. Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 19: 244–250, 1979

    PubMed  Google Scholar 

  • Van Ganse W, Reyntjens A. Clinical evaluation of cisapride in postprandial dyspepsia. Progress in Medicine 43 (Suppl. 1): 77–81, 1987

    Google Scholar 

  • Van Ganse W, Van Damme L, Van de Mierop L, Deruyttere M, Lauwers W, et al. Chronic dyspepsia: double-blind treatment with domperidone (R33812) or a placebo. A multi-centre therapeutic evaluation. Current Therapeutic Research 23: 695–701, 1978

    Google Scholar 

  • Van Outyre M, van Egham P, Reyntjens A. Cisapride in the treatment of non-ulcer dyspepsia patients, unresponsive to domperidone or metocloprarnide: a multicentre, double-blind, placebo-controlled study. World Congresses of Gastroenterology, Sydney, August 1990. Abstract FP628, 1990.

  • Veldhuyzen van Zanten SJO, Tytgat KMAJ, Jali S, Goodacre RL, Hunt RH. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, non-ulcer dyspepsia and Campylobacter associated gastritis. Journal of Clinical Gastroenterology 11: 496–501, 1989

    Article  CAS  PubMed  Google Scholar 

  • Verhaegen H, de Cree J, Leempoels J. Treatment of chronic dyspepsia with cisapride and domperidone. Acta Therapeutica 13: 385–394, 1987

    Google Scholar 

  • Walters JM, Crean P, McCarthy CF. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Irish Journal of Medicine 73: 380–381, 1980

    CAS  Google Scholar 

  • Weberg R, Berstad A. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial. Scandinavian Journal of Gastroenterology 23: 237–243, 1988

    CAS  PubMed  Google Scholar 

  • Weihrauch TR, Forster CRF, Krieglstein J. Evaluation of the effect of domperidone on human esophageal and gastroduodenal motility by intraluminal manometry. Postgraduate Medical Journal 55: 7, 1979

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of Essen, Essen, Germany

    Gerald Holtmann

  2. Division of Gastroenterology and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, 55905, USA

    Nicholas J. Talley (Associate Professor of Medicine)

Authors
  1. Gerald Holtmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas J. Talley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holtmann, G., Talley, N.J. Functional Dyspepsia. Drugs 45, 918–930 (1993). https://doi.org/10.2165/00003495-199345060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199345060-00005

Keywords

Search

Navigation